Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway

Fig. 3

MLH1 enhanced cisplatin-induced apoptosis in endometrial carcinoma cells in vitro. a Apoptosis rate of RL95–2 cell 72 h after treatment with 5 μmol cisplatin. b Apoptosis rate of Ishikawa cell 72 h after treatment with 25 μmol cisplatin, detected by flow cytometry analysis. UR indicates late apoptosis cells; LR indicates early apoptosis cells

Back to article page
\